KHDRBS1 as a novel prognostic signaling biomarker influencing hepatocellular carcinoma cell proliferation, migration, immune microenvironment, and drug sensitivity

KHDRBS1 as a novel prognostic signaling biomarker influencing hepatocellular carcinoma cell proliferation, migration, immune microenvironment, and drug sensitivity

BackgroundHuman tumors pose significant challenges, with targeted therapy against specific molecular targets or signaling pathways being a mainstay alongside surgical resection. Previous studies have implicated KHDRBS1 in the oncogenesis of certain human tumors such as colorectal and prostate cancer...

Full description

Bibliographic Details
Main Authors:	Rui Fan, Fahui Liu, Qiming Gong, Donghua Liu, Shihang Tang, Dongyan Shen
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2024-04-01
Series:	Frontiers in Immunology
Subjects:	HCC KHDRBS1 immune migration multi-omics biomarker
Online Access:	https://www.frontiersin.org/articles/10.3389/fimmu.2024.1393801/full

Similar Items

Evolutionary and Expression Analyses Show Co-option of khdrbs Genes for Origin of Vertebrate Brain
by: Su Wang, et al.
Published: (2018-01-01)

circHECTD1 Promotes the Proliferation and Migration of Human Brain Vascular Smooth Muscle Cells via Interacting with KHDRBS3 to Stabilize EZH2 mRNA Expression
by: Feng M, et al.
Published: (2023-03-01)

KHDRBS3 accelerates glycolysis and promotes malignancy of hepatocellular carcinoma via upregulating 14-3-3ζ
by: Mingda Zhao, et al.
Published: (2023-10-01)

Sam68/KHDRBS1-dependent NF-κB activation confers radioprotection to the colon epithelium in γ-irradiated mice
by: Kai Fu, et al.
Published: (2016-12-01)

Sam68/KHDRBS1 is critical for colon tumorigenesis by regulating genotoxic stress-induced NF-κB activation
by: Kai Fu, et al.
Published: (2016-07-01)

Machine learning-based integration develops a neutrophil-derived signature for improving outcomes in hepatocellular carcinoma
by: Qiming Gong, et al.
Published: (2023-07-01)

Leptin, Leptin Receptor, KHDRBS1 (KH RNA Binding Domain Containing, Signal Transduction Associated 1), and Adiponectin in Bone Metastasis from Breast Carcinoma: An Immunohistochemical Study
by: Paola Maroni, et al.
Published: (2020-11-01)

The Prognostic and Immunotherapeutic Significance of AHSA1 in Pan-Cancer, and Its Relationship With the Proliferation and Metastasis of Hepatocellular Carcinoma
by: Wenli Li, et al.
Published: (2022-06-01)

FBXO43 increases CCND1 stability to promote hepatocellular carcinoma cell proliferation and migration
by: Chun-Ming Li, et al.
Published: (2023-03-01)

Swertiamarin suppresses proliferation, migration, and invasion of hepatocellular carcinoma cells <em>via</em> negative regulation of FRAT1
by: Shufeng Xiao, et al.
Published: (2020-10-01)

Adenovirus-mediated Hes1 Expression Inhibits Proliferation and Migration of Hepatocellular Carcinoma Cells
by: YU Bing, et al.
Published: (2020-03-01)

SLM2 Is A Novel Cardiac Splicing Factor Involved in Heart Failure due to Dilated Cardiomyopathy
by: Jes-Niels Boeckel, et al.
Published: (2022-02-01)

A Multi-Omics Analysis of NASH-Related Prognostic Biomarkers Associated with Drug Sensitivity and Immune Infiltration in Hepatocellular Carcinoma
by: Yongting Liu, et al.
Published: (2023-02-01)

Twist Promotes the Migration of Hepatocellular Carcinoma Cells
by: Zhao WEI, et al.
Published: (2009-10-01)

Mapping Transgene Insertion Sites Reveals Complex Interactions Between Mouse Transgenes and Neighboring Endogenous Genes
by: Mallory A. Laboulaye, et al.
Published: (2018-10-01)

Multi-omics data integration reveals novel drug targets in hepatocellular carcinoma
by: Christos Dimitrakopoulos, et al.
Published: (2021-08-01)

Transgenic zebrafish for modeling hepatocellular carcinoma
by: Joji Nakayama, et al.
Published: (2020-09-01)

CMTM6 promotes migration, invasion, and EMT by interacting with and stabilizing vimentin in hepatocellular carcinoma cells
by: Xiaoting Huang, et al.
Published: (2021-03-01)

ALYREF associated with immune infiltration is a prognostic biomarker in hepatocellular carcinoma
by: Zhen-Zhen Wang, et al.
Published: (2022-07-01)

Suppression of Heterogeneous Nuclear Ribonucleoprotein C Inhibit Hepatocellular Carcinoma Proliferation, Migration, and Invasion via Ras/MAPK Signaling Pathway
by: Jiejun Hu, et al.
Published: (2021-04-01)

Key Candidate Prognostic Biomarkers Correlated with Immune Infiltration in Hepatocellular Carcinoma
by: Deng Z, et al.
Published: (2021-12-01)

Prognostic clinical phenotypes associated with tumor stemness in the immune microenvironment of T-cell exhaustion for hepatocellular carcinoma
by: Genhao Zhang
Published: (2023-11-01)

Phosphoribosyl Pyrophosphate Amido Transferase: A New Prognostic Biomarker for Hepatocellular Carcinoma
by: Chu Q, et al.
Published: (2022-01-01)

Multidimensional landscape of non‐alcoholic fatty liver disease‐related disease spectrum uncovered by big omics data: Profiling evidence and new perspectives
by: Zhengyi Zhu, et al.
Published: (2023-05-01)

Prognostic Lysosome-Related Biomarkers for Predicting Drug Candidates in Hepatocellular Carcinoma: An Insilco Analysis
by: Xu J, et al.
Published: (2023-03-01)

Integrative pan-cancer landscape of MMS22L and its potential role in hepatocellular carcinoma
by: Zhiting Guo, et al.
Published: (2022-10-01)

Analysis of cuproptosis in hepatocellular carcinoma using multi-omics reveals a comprehensive HCC landscape and the immune patterns of cuproptosis
by: Xinqiang Li, et al.
Published: (2022-11-01)

Malic enzyme 2 promotes the progression of hepatocellular carcinoma via increasing triglyceride production
by: Shuai Zhang, et al.
Published: (2021-10-01)

Prognostic Biomarker DDOST and Its Correlation With Immune Infiltrates in Hepatocellular Carcinoma
by: Changyu Zhu, et al.
Published: (2022-01-01)

USP40 promotes hepatocellular carcinoma cell proliferation, migration and stemness by deubiquitinating and stabilizing Claudin1
by: Qingsong Wu, et al.
Published: (2024-02-01)

UCHL3 promotes hepatocellular carcinoma cell migration by de-ubiquitinating and stabilizing Vimentin
by: Qiancheng Ma, et al.
Published: (2023-03-01)

Knockdown of NDUFC1 inhibits cell proliferation, migration, and invasion of hepatocellular carcinoma
by: Fang Han, et al.
Published: (2022-09-01)

Identification of a Prognostic Model Based on 2-Gene Signature and Analysis of Corresponding Tumor Microenvironment in Alcohol-Related Hepatocellular Carcinoma
by: Yong Guo, et al.
Published: (2021-09-01)

Immune landscape of hepatocellular carcinoma tumor microenvironment identifies a prognostic relevant model
by: Hongru Cao, et al.
Published: (2024-02-01)

The gene expression signature of metabolic dysfunction- associated steatotic liver disease from a multiomics perspective
by: Carlos Jose Pirola, et al.
Published: (2024-04-01)

MARCKS is a New Prognostic Biomarker in Hepatocellular Carcinoma
by: Lu H, et al.
Published: (2023-05-01)

Integrated Proteomics and Bioinformatics to Identify Potential Prognostic Biomarkers in Hepatocellular Carcinoma
by: Zhang Q, et al.
Published: (2021-03-01)

Cell division cycle‐associated 8 is a prognostic biomarker related to immune invasion in hepatocellular carcinoma
by: Haomin Wu, et al.
Published: (2023-04-01)

The prognostic value of the GPAT/AGPAT gene family in hepatocellular carcinoma and its role in the tumor immune microenvironment
by: Peizhen Wen, et al.
Published: (2023-02-01)

Identification of HM13 as a prognostic indicator and a predictive biomarker for immunotherapy in hepatocellular carcinoma
by: Genhao Zhang, et al.
Published: (2022-08-01)